Qure Ventures

About Qure Ventures

Qure Ventures manages a globally focused venture fund (US$50mn in size) that invests in clinically relevant digital health solutions and is a strategic innovation partner for leading healthcare organisations. To leverage its returns potential, Qure has signed strategic partnership agreements that provide Qure and its portfolio companies with strong validation and clinical and commercial support.

Qure has successfully built, implemented and invested in some of the largest and most successful digital health solutions in the world, including being responsible for leading the digital transformation of the Israeli healthcare system. These solutions have been tailored and executed for Government health departments, pharmaceutical companies, healthcare providers, insurance companies and other organisations.

Qure focuses on technologies that significantly improve quality of patient care and health services, reduce costs of healthcare delivery, create transparency of information and empower consumers to make better health choices. Key areas of focus include artificial intelligence, genomics, big data and analytics, cybersecurity in healthcare, personalised medicine and telemedicine. Companies that Qure has partnered with/invested in include:

• TytoCare – an FDA approved device that enables a comprehensive medical examination done by the patient themselves from any location
• Medisafe – a personalised medication management platform
• Zebra Medical – an AI-based medical image diagnostic solution
• CyberMDX – a preventative cybersecurity solution focused on connected medical devices at hospitals and smart medical homes
• Sweetch – an AI-based platform for health promotion as well as chronic disease prevention and management